• Esbriet Seen to Offer Significant Benefits to IPF Patients in Pooled Analysis of Phase 3 Trials
  • IPF and Emotional Outbursts: Why Are They Happening?
  • PMD Healthcare Among Those Marking PF Awareness Month with New Tools for Patients
  • Boehringer Ingelheim Marks IPF Week with App That Helps Doctors Recognize Diseased Lungs’ Sounds
  • Handling PF on My Own
  • Phase 2 Results Demonstrate Potential of FibroGen’s Pamrevlumab to Treat IPF
  • When Illness Dictates Significant Lifestyle Changes
  • Study Supports Inhaled Version of miRagen’s MRG-201 as Lung Fibrosis Therapy
  • 2 Distinct Groups of Lung Cells Seen to Play ‘Good’ and ‘Bad’ Roles in Diseases Like IPF
  • Supplemental Oxygen and the Life of a Young Adult
  • Synairgen and Pharmaxis Preparing Phase 1 Trial of Potential Fibrosis Therapy
  • Ofev-Esbriet Combo Is as Safe as Individual Components as a Pulmonary Fibrosis Therapy, Trial Indicates